HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS British Journal of Psychiatry Advances in Psychiatric Treatment All RCPsych Journals		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Cooray, S. E. Articles by Tolmac, J. Search for Related Content PubMed Articles by Cooray, S. E. Articles by Tolmac, J.

Antipsychotic medication in learning disability

Impact of audit and evidence-based medicine on quality of prescribing in a community assessment treatment unit

Parkside Health Trust, Kingsbury Community Hospital, Honeypot Lane, London NW9 9QY

^* Correspondence

Aims and method Antipsychotic medication, an effective treatment modality in the management of psychiatric/behaviour disorders in people with learning disability, is often criticised because of poor clinical practice. Rational and judicious use, subject to evidence-based guidelines and systematic monitoring, is mandatory. A five-year clinical audit programme on the quality of prescribing for this clientele was undertaken.

Results Significant quality improvement with minimal resource consumption was demonstrated.

Clinical implications Clinical audit facilitates high-quality prescribing: pragmatic and economic, it can easily be integrated into routine clinical practice.